Vitestro, founded in 2017, is pioneering the way in healthcare technology with its breakthrough in autonomous blood drawing solutions. With the compelling slogan, "We transform patient care with autonomous blood drawing technology", the company stands at the forefront of the Health Care and Medical Devices industries.
The Netherlands-based startup addresses critical gaps in healthcare, with traditional blood drawing being a pivotal diagnostic tool that's performed billions of times annually. As the demand for diagnostics surges due to population growth and workforce shortages, Vitestro offers a much-needed future-proof solution for European hospitals.
The company recently secured a €20.00M Series A investment on 30 April 2024, demonstrating strong confidence from investors. This round was led by the European Innovation Council, Invest-NL, Sonder Capital, and NYBC Ventures, underscoring a significant vote of confidence in Vitestro's innovative approach to medical advancements.